As of 2025, Takeda Pharmaceutical has disclosed 5 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 5 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Takeda Pharmaceutical's climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -40%a, b | 2025 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -25%a | 2030 |
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -65%a | 2030 |
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -90%a | 2035 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -90%a | 2040 |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
As of 2025, Takeda Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.ab
As of 2025, Takeda Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.ab
Takeda Pharmaceutical's most ambitious operational target is to reduce these emissions by 40% by 2025, compared to a baseline of 690,166 Metric Tonnes of CO2 equivalent (mtCO2e) in 2016.ab
Takeda Pharmaceutical has already surpassed its operational emissions reduction target, with 2024 levels falling below the 2025 value, achieving its climate goal ahead of schedule.ab